RecruitingNCT02835911

Clinical Cohort of Lymphoma Patients in Malawi

LCCC 1229: Developing a Prospective Lymphoma Clinical Cohort in Malawi

Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment

800 participants

Start Date

Nov 1, 2012

Study Type

OBSERVATIONAL

Conditions

Lymphoma Hematologic Malignancies

Summary

This registry study is intended to establish a large prospective longitudinal clinical cohort of lymphoma patients in Malawi, as such data is currently lacking from sub-Saharan Africa. The investigators will perform core biopsies on at least 800 consecutively enrolled patients with suspected lymphoma for accurate histopathologic characterization. The investigators will systematically collect relevant clinical and laboratory data, and longitudinally follow those with confirmed hematologic malignancies receiving treatment according to local standards of care to assess outcomes.

Eligibility

Min Age: 0 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is enrolling patients in Malawi who are suspected of having lymphoma — a type of blood cancer affecting the lymph nodes — to build a clinical database that helps researchers understand this disease in the region and improve diagnosis and treatment. **You may be eligible if...** - You have been referred to Kamuzu Central Hospital with a clinical suspicion of lymphoma - You are older than 5 years old, OR you are 5 years or younger only if lymphoma has already been confirmed by a lab test - You have not previously been diagnosed with or treated for any cancer - You live within 200 kilometers of Kamuzu Central Hospital - You or your parent/guardian can understand and sign a consent form in English or Chichewa **You may NOT be eligible if...** - There are no additional exclusion criteria for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

UNC Project

Lilongwe, Malawi

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02835911

Related Trials

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT0662408516 locations

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

NCT0608493676 locations

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT0719591622 locations

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT052379863 locations

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893121 locations